Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 15 2024
0mins
Source: Yahoo Finance
- Participants: Charles Theuer, Scott Brown, and Matt Venezia from TRACON Pharmaceuticals Inc.
- Presentation: Overview of TRACON Pharmaceuticals' first-quarter 2024 earnings conference call, including forward-looking statements, financial results, and business updates.
- Pipeline Update: Progress on the ongoing Phase 2 ENVASARC pivotal trial for enva treatment in sarcoma subtypes UPS and MFS.
- Product Development Platform (PDP): Discussion on leveraging PDP for non-dilutive capital through clinical trials and licensing agreements.
- Financials: Review of TRACON's research and development expenses, general administrative expenses, net loss, and balance sheet status.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
